Search

Your search keyword '"Andrieu-Abadie, Nathalie"' showing total 332 results

Search Constraints

Start Over You searched for: Author "Andrieu-Abadie, Nathalie" Remove constraint Author: "Andrieu-Abadie, Nathalie"
332 results on '"Andrieu-Abadie, Nathalie"'

Search Results

2. Sphingolipid paracrine signaling impairs keratinocyte adhesion to promote melanoma invasion

4. Contribution of Keratinocytes in Skin Cancer Initiation and Progression.

5. Ceramide metabolism alterations contribute to Tumor Necrosis Factor-induced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients.

6. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

9. Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells

10. Guidelines for the use and interpretation of assays for monitoring autophagy.

11. Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

15. Data from Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy

16. Supplementary Data File S1 from Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy

17. Supplementary Tables and Figures from Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy

18. Supplementary Data from Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas

19. Supplementary Figure S3 from Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas

20. Supplementary information from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma

21. Supplementary Figure S5 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma

22. Data from Disruption of Sphingosine 1-Phosphate Lyase Confers Resistance to Chemotherapy and Promotes Oncogenesis through Bcl-2/Bcl-xL Upregulation

23. Supplementary Materials, Figures 1-5 from Disruption of Sphingosine 1-Phosphate Lyase Confers Resistance to Chemotherapy and Promotes Oncogenesis through Bcl-2/Bcl-xL Upregulation

30. PARKIN Inactivation Links Parkinson’s Disease to Melanoma

34. Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy

35. Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial

36. Genetic Disorders of Simple Sphingolipid Metabolism

45. Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy

46. Ceramide in Apoptosis

Catalog

Books, media, physical & digital resources